NeuroPace
NPCE· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock +38.0% in FY2025
Joel Becker is the CEO of NeuroPace and was paid $2.4M in FY2025 (Dec), down 20%.
Pay$100 in the stock at the end of FY22 → $1.0K
Executives4
See all- 1Joel BeckerPresident and Chief Executive OfficerFY2025
- 2Patrick WilliamsChief Financial OfficerFY2025
- 3Martha Morrell, M.D.Chief Medical OfficerFY2025
- 4Rebecca KuhnFormer Chief Financial Officer, Vice President, Finance and AdministrationFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allNeuroPace paid its 4 named executives $5.9M in total in FY2025 (Dec). CEO Joel Becker was paid $2.4M of that.
| Name | |||
|---|---|---|---|
| Joel BeckerPresident and Chief Executive Officer | |||
| Patrick WilliamsChief Financial Officer | Not disclosed | Not disclosed | |
| Martha Morrell, M.D.Chief Medical Officer | |||
| Rebecca KuhnFormer Chief Financial Officer, Vice President, Finance and Administration |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for NeuroPace. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board4
See all- Renee RyanDirector · 12 yr on the boardIndependentAudit, Compensation—Paid as an executive
- Lisa AndradeDirector · 4 yr on the boardIndependentCompensation, Nominating and Corporate Governance (Chair)—Paid as an executive
- Rakhi KumarDirector · 4 yr on the boardIndependentAudit (Chair)—Paid as an executive
- Uri GeigerDirector · 2 yr on the boardIndependentCompensation—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 21, 2026 | FY2025 |
| Annual report | 10-K | Mar 3, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 22, 2025 | FY2024 |
| Annual report | 10-K | Mar 4, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 22, 2024 | FY2023 |
| Annual report | 10-K | Mar 5, 2024 | FY2023 |
